# Glenmark Pharmaceuticals Limited – FDA Inspection, Aug 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/84e00ca0-c1d9-49f1-aa35-11332d0d7eec
Source feed: FDA_Inspections

> FDA inspection 1065438 of Glenmark Pharmaceuticals Limited, August 17, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1065438
- Company Name: Glenmark Pharmaceuticals Limited
- Inspection Date: 2018-08-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1298220 - 2025-11-28
- FDA Inspection 1252922 - 2024-09-20
- FDA Inspection 1226884 - 2023-12-15
- [FDA Inspection 1122444 - 2020-02-21](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/7480abca-376a-48b0-8d6c-47a32ec70561)
- FDA Inspection 1025068 - 2017-07-21

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/dacc6330-129c-4ce4-8c41-f71525daebe5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c